LUDWIG HANTSON Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LUDWIG HANTSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUDWIG HANTSON. LUDWIG HANTSON is Corporate Vice President in BAXTER INTERNATIONAL INC ($BAX) and Director in HOLOGIC INC ($HOLX) and CEO in ALEXION PHARMACEUTICALS INC ($ALXN) and Chairman of the Board and CEO in Baxalta Inc ($BXLT) and President and CEO in Baxalta Inc ($BXLT).
LUDWIG HANTSON in ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LUDWIG HANTSON: CEO
Holdings: 349,166 shares
Current Value: $44,595,482
Latest Transaction: Apr 01 2021
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LUDWIG HANTSON in ALEXION PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, BXLT, BAX, HOLX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 154.03 | 2,332 | 359,198 | 349,166 | 351.5 K to 349.2 K (-0.66 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 157.96 | 13,059 | 2,062,800 | 267,773 | 280.8 K to 267.8 K (-4.65 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 157.96 | 72,533 | 11,457,313 | 280,832 | 353.4 K to 280.8 K (-20.53 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Grant | A | 0.00 | 162,707 | 0 | 353,365 | 190.7 K to 353.4 K (+85.34 %) |
| Mar 31 2020 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 85.43 | 3,202 | 273,547 | 190,658 | 193.9 K to 190.7 K (-1.65 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Grant | A | 0.00 | 37,198 | 0 | 170,836 | 133.6 K to 170.8 K (+27.83 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 132.92 | 4,043 | 537,396 | 133,638 | 137.7 K to 133.6 K (-2.94 %) |
| Feb 11 2019 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 119.57 | 13,015 | 1,556,204 | 137,681 | 150.7 K to 137.7 K (-8.64 %) |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Sell | S | 116.31 | 13,245 | 1,540,526 | 118,180 | 131.4 K to 118.2 K (-10.08 %) |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Grant | A | 0.00 | 95,253 | 0 | 131,425 | 36.2 K to 131.4 K (+263.33 %) |
| Jan 04 2018 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Sell | S | 121.63 | 2,553 | 310,521 | 36,172 | 38.7 K to 36.2 K (-6.59 %) |
| Jun 19 2017 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Buy | P | 116.72 | 10,000 | 1,167,200 | 38,725 | 28.7 K to 38.7 K (+34.81 %) |
| Mar 29 2017 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Option Exercise | A | 118.83 | 56,762 | 6,745,028 | 56,762 | |
| Mar 29 2017 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Grant | A | 0.00 | 28,725 | 0 | 57,450 | 28.7 K to 57.5 K (+100.00 %) |
Page: 1